深部静脈血栓症（DVT）の世界市場（2025年）

世界の深部静脈血栓症（DVT）の市場規模は、今後数年間に安定した成長が見込まれており、2029年に13億2,000万米ドルに達すると予測され、CAGRで4.6%の成長が見込まれます。予測期間の成長は、老年人口の増加、生活習慣病の罹患率の上昇、予防医療の重視、革新的な治療法、患者中心のケアの重視などに起因すると考えられます。予測期間の主要動向は、危険因子の認識、診断の進歩、治療の革新、公衆衛生への取り組み、術後の予防などです。

深部静脈血栓症（DVT）治療に対する需要の高まりは、今後数年間のDVT市場の拡大を促進すると予測されます。DVT治療には、深部静脈血栓症（DVT）患者の血栓の形成と拡大を抑制するための抗凝固薬などの薬剤の投与が含まれます。DVT治療を希望する患者数の増加は、深部静脈血栓症（DVT）の有病率の上昇を示しており、DVTの診断、予防、治療用の製品の開発が必要とされています。2023年2月、米国疾病予防管理センター（CDC）は、米国では年間推定90万人が深部静脈血栓症（DVT）に罹患する可能性があり、毎年6万人～10万人の米国人がDVTまたは肺塞栓症で死亡すると報告しています。結果として、DVT治療に対する需要の高まりが市場成長の主な促進要因となっています。

肥満の増加は、深部静脈血栓症（DVT）市場の成長を促進します。肥満は過剰な体脂肪の蓄積を特徴とする病状であり、さまざまな健康リスクや合併症を引き起こします。DVTと肺塞栓症（PE）を含む静脈血栓塞栓症（VTE）の独立した中等度の危険因子であることから、DVT治療は肥満を管理する上で重要な役割を担っています。2023年3月の時点で、World Heart Federationは、全世界で約23億人の成人と小児が肥満または過体重であると発表しています。この肥満の動向から、2025年までに肥満患者は27億人に達すると予測されています。したがって、肥満の蔓延が深部静脈血栓症（DVT）市場の成長の促進要因となっています。

当レポートでは、世界の深部静脈血栓症（DVT）市場について調査分析し、市場の特徴、市場の動向と戦略、各地域の分析、競合情勢などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 深部静脈血栓症（DVT）市場の特徴

第3章 深部静脈血栓症（DVT）市場の動向と戦略

第4章 深部静脈血栓症（DVT）市場 - 市場に対する金利、インフレ、地政学、COVIDと回復の影響を含むマクロ経済シナリオ

第5章 世界の深部静脈血栓症（DVT）の成長分析、戦略的分析フレームワーク

• 世界の深部静脈血栓症（DVT）に関するPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の深部静脈血栓症（DVT）市場の成長率分析
• 世界の深部静脈血栓症（DVT）の市場規模と成長の実績（2019年～2024年）
• 世界の深部静脈血栓症（DVT）の市場規模と成長の予測（2024年～2029年・2034年）
• 世界の深部静脈血栓症（DVT）の総市場規模（TAM）

第6章 深部静脈血栓症（DVT）の市場のセグメンテーション

• 世界の深部静脈血栓症（DVT）市場：薬剤クラス別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 抗凝固剤
• 下大静脈フィルター
• その他の薬剤クラス
• 世界の深部静脈血栓症（DVT）市場：治療別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 手術
• 薬剤
• その他の治療法
• 世界の深部静脈血栓症（DVT）市場：投与方式別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 注射
• 経口
• その他の作用機序
• 世界の深部静脈血栓症（DVT）市場：流通チャネル別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の深部静脈血栓症（DVT）市場：エンドユーザー別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 病院
• 在宅ケア
• 専門クリニック
• その他のエンドユーザー
• 世界の深部静脈血栓症（DVT）市場、抗凝固剤のサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 直接経口抗凝固薬（DOAC）
• ビタミンK拮抗薬
• 低分子ヘパリン
• 未分画ヘパリン
• 世界の深部静脈血栓症（DVT）市場、下大静脈フィルターのサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 回収可能型IVCフィルター
• 永久留置型IVCフィルター
• 先進IVCフィルターシステム
• 世界の深部静脈血栓症（DVT）市場、その他の薬剤クラスのサブセグメンテーション：タイプ別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 血栓溶解剤
• 抗血小板薬
• 線維素溶解薬
• 併用療法

第7章 深部静脈血栓症（DVT）市場の地域と国の分析

• 世界の深部静脈血栓症（DVT）市場：地域別、実績と予測（2019年～2024年・2024年～2029年・2034年）
• 世界の深部静脈血栓症（DVT）市場：国別、実績と予測（2019年～2024年・2024年～2029年・2034年）

第8章 アジア太平洋の深部静脈血栓症（DVT）市場

第9章 中国の深部静脈血栓症（DVT）市場

第10章 インドの深部静脈血栓症（DVT）市場

第11章 日本の深部静脈血栓症（DVT）市場

第12章 オーストラリアの深部静脈血栓症（DVT）市場

第13章 インドネシアの深部静脈血栓症（DVT）市場

第14章 韓国の深部静脈血栓症（DVT）市場

第15章 西欧の深部静脈血栓症（DVT）市場

第16章 英国の深部静脈血栓症（DVT）市場

第17章 ドイツの深部静脈血栓症（DVT）市場

第18章 フランスの深部静脈血栓症（DVT）市場

第19章 イタリアの深部静脈血栓症（DVT）市場

第20章 スペインの深部静脈血栓症（DVT）市場

第21章 東欧の深部静脈血栓症（DVT）市場

第22章 ロシアの深部静脈血栓症（DVT）市場

第23章 北米の深部静脈血栓症（DVT）市場

第24章 米国の深部静脈血栓症（DVT）市場

第25章 カナダの深部静脈血栓症（DVT）市場

第26章 南米の深部静脈血栓症（DVT）市場

第27章 ブラジルの深部静脈血栓症（DVT）市場

第28章 中東の深部静脈血栓症（DVT）市場

第29章 アフリカの深部静脈血栓症（DVT）市場

第30章 深部静脈血栓症（DVT）市場の競合情勢と企業プロファイル

• 深部静脈血栓症（DVT）市場の競合情勢
• 深部静脈血栓症（DVT）市場の企業プロファイル
  • Abbott Laboratories
  • Bristol-Myers Squibb Company
  • Sanofi-Aventis US LLC
  • Daiichi Sankyo Company Limited
  • Aspen Pharmacare Holdings Limited

第31章 深部静脈血栓症（DVT）市場のその他の主要企業と革新企業

• Novartis AG
• Mylan N.V.
• Bayer AG
• Boehringer Ingelheim GmbH
• Medtronic PLC
• Hikma Pharmaceuticals PLC
• Laboratorios Farmaceuticos Rovi S.A.
• Cardinal Health Inc.
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca PLC
• Stryker Corporation
• Cook Medical Incorporated
• Boston Scientific Corporation
• Arjo AB
• DJO Global Inc.

第32章 世界の深部静脈血栓症（DVT）市場の競合ベンチマーキングとダッシュボード

第33章 深部静脈血栓症（DVT）市場における主な合併と買収

第34章 深部静脈血栓症（DVT）市場の近年の発展

第35章 深部静脈血栓症（DVT）市場の潜在性が高い国、セグメント、戦略

• 深部静脈血栓症（DVT）市場 - もっとも新しい機会を提供する国（2029年）
• 深部静脈血栓症（DVT）市場 - もっとも新しい機会を提供するセグメント（2029年）
• 深部静脈血栓症（DVT）市場 - 成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Deep vein thrombosis (DVT) is a serious medical condition characterized by the formation of blood clots in one or more deep veins within the body. Commonly, this condition manifests with symptoms such as swelling, pain, and tenderness in the affected area, typically the leg.

The primary categories of drugs utilized in the treatment of deep vein thrombosis include anticoagulants, inferior vena cava filters, and other therapeutic options. Anticoagulants, commonly referred to as blood thinners, are medications designed to prevent the formation of blood clots in the blood vessels. Treatment approaches for DVT encompass surgical interventions, pharmaceutical interventions, and other modalities. These treatments may be administered through various routes, including injectable, oral, and other methods. The distribution channels for these medications include hospital pharmacies, retail pharmacies, and online pharmacies. Additionally, the end-users for these drugs span diverse healthcare settings such as hospitals, homecare, specialty clinics, and others.

The deep vein thrombosis market research report is one of a series of new reports from The Business Research Company that provides deep vein thrombosis market statistics, including deep vein thrombosis industry global market size, regional shares, competitors with a deep vein thrombosis market share, detailed deep vein thrombosis market segments, market trends and opportunities, and any further data you may need to thrive in the deep vein thrombosis industry. This deep vein thrombosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deep vein thrombosis market size has grown steadily in recent years. It will grow from$1.06 billion in 2024 to $1.1 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increased vascular medicine specialization, influence of medical guidelines, focus on thrombosis prevention, clinical research development, increased diagnosis awareness

The deep vein thrombosis market size is expected to see steady growth in the next few years. It will grow to $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing aging population, rising incidence of lifestyle diseases, preventive healthcare emphasis, innovative therapies, focus on patient-centric care. Major trends in the forecast period include risk factors awareness, advancements in diagnosis, treatment innovations, public health initiatives, post-surgical prevention.

The escalating demand for deep vein thrombosis (DVT) treatment is anticipated to fuel the expansion of the DVT market in the coming years. DVT treatment involves the administration of drugs, including anticoagulants, to mitigate the formation and enlargement of blood clots in individuals with deep vein thrombosis. The growing number of patients seeking DVT treatment signals an upsurge in the prevalence of deep vein thrombosis, necessitating the development of products for DVT diagnosis, prevention, and treatment. In February 2023, the Centers for Disease Control and Prevention (CDC) reported that an estimated 900,000 people in the United States could be affected annually by deep vein thrombosis, with 60,000 to 100,000 Americans succumbing to DVT or pulmonary embolism each year. Consequently, the rising demand for DVT treatment is a key driver propelling market growth.

The increasing incidence of obesity is poised to drive the growth of the deep vein thrombosis market. Obesity, a medical condition characterized by the accumulation of excess body fat, poses various health risks and complications. DVT treatment assumes a crucial role in managing obesity, given its status as an independent and moderate risk factor for venous thromboembolism (VTE), encompassing DVT and pulmonary embolism (PE). As of March 2023, the World Heart Federation disclosed that approximately 2.3 billion adults and children globally are either obese or overweight. With the prevailing obesity trend, projections indicate that the number of individuals living with obesity will reach 2.7 billion by 2025. Hence, the mounting prevalence of obesity stands as a driving force behind the growth of the deep vein thrombosis market.

The deep vein thrombosis market is witnessing a significant trend towards product innovation, with major industry players actively integrating advanced technologies to introduce novel products and fortify their market positions. A case in point is Penumbra Inc., a renowned US-based developer specializing in groundbreaking therapies. In January 2023, the company unveiled Lightning Flash, a state-of-the-art mechanical thrombectomy system meticulously engineered to tackle venous and pulmonary thrombus challenges. This innovative system showcases Penumbra's proprietary lightning-intelligent aspiration technology alongside cutting-edge dual clot detection algorithms. Specifically designed to swiftly address substantial blood clots, including venous thrombus and pulmonary emboli (PE), Lightning Flash equips physicians with a robust, high-torque catheter optimized for the efficient removal of clot burdens in both pulmonary arteries and the deep venous system. Notably, this system upholds an exemplary safety profile, underscoring its potential as a pivotal advancement in DVT treatment modalities.

Major players in the deep vein thrombosis (DVT) market are actively engaging in strategic partnerships to expedite the diagnosis of DVT and optimize their market profitability. This strategic approach underscores a growing interest in harnessing the capabilities of artificial intelligence (AI) and machine learning to enhance medical diagnostics, particularly in the swift and precise identification of DVT. A notable example occurred in November 2023 when UK-based ultrasound AI company ThinkSono Ltd. collaborated with US-based academic medical center NYU Langone Health. Together, they initiated the first clinical trial for an innovative AI-powered ultrasound software, known as the ThinkSono Guidance System. This technology aims to revolutionize the diagnosis of DVT by leveraging AI to potentially achieve faster, more precise, and cost-effective results compared to traditional techniques. The trial involves the utilization of the ThinkSono Guidance System alongside standard ultrasound scanning in patients with and without DVT. The performance of the two approaches will be rigorously assessed to confirm the accuracy of the ThinkSono system. The trial will also benefit from the participation of medical students from the NYU Grossman School of Medicine, contributing to the practical research curriculum.

In March 2024, Pfizer Inc., a U.S.-based biopharmaceutical company, partnered with Bristol-Myers Squibb (BMS) to provide grant support for ongoing professional education focused on anticoagulation in atrial fibrillation and venous thromboembolism. This collaboration encourages organizations to apply for grants that support independent educational initiatives aimed at enhancing the understanding of oral anticoagulant treatments for patients with atrial fibrillation and venous thromboembolism. Bristol-Myers Squibb is also a U.S.-based pharmaceutical company.

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmaceuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.

North America was the largest region in the deep vein thrombosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the deep vein thrombosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The deep vein thrombosis market includes revenues earned by entities by providing services related to treatment such as blood thinning medication, thrombolytic therapy, interventional radiology therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deep Vein Thrombosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deep vein thrombosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deep vein thrombosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The deep vein thrombosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Anticoagulants; Inferior Vena Cava Filters; Other Drug Class
• 2) By Treatment: Surgery; Drugs; Other Treatments
• 3) By Mode Of Administration: Injectable; Oral; Other Modes Of Action
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End-users
• Subsegments:
• 1) By Anticoagulants: Direct Oral Anticoagulants (DOACs); Vitamin K Antagonists; Low Molecular Weight Heparins; Unfractionated Heparin
• 2) By Inferior Vena Cava Filters: Retrievable IVC Filters; Permanent IVC Filters; Advanced IVC Filter Systems
• 3) By Other Drug Class: Thrombolytics; Antiplatelet Agents; Fibrinolytics; Combination Therapy
• Companies Mentioned: Abbott Laboratories; Bristol-Myers Squibb Company; Sanofi-Aventis U.S. LLC; Daiichi Sankyo Company Limited; Aspen Pharmacare Holdings Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Deep Vein Thrombosis Market Characteristics

3. Deep Vein Thrombosis Market Trends And Strategies

4. Deep Vein Thrombosis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Deep Vein Thrombosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Deep Vein Thrombosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Deep Vein Thrombosis Market Growth Rate Analysis
• 5.4. Global Deep Vein Thrombosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Deep Vein Thrombosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Deep Vein Thrombosis Total Addressable Market (TAM)

6. Deep Vein Thrombosis Market Segmentation

• 6.1. Global Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Inferior Vena Cava Filters
• Other Drug Class
• 6.2. Global Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Drugs
• Other Treatments
• 6.3. Global Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Other Modes Of Action
• 6.4. Global Deep Vein Thrombosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Deep Vein Thrombosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-users
• 6.6. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Anticoagulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Oral Anticoagulants (DOACs)
• Vitamin K Antagonists
• Low Molecular Weight Heparins
• Unfractionated Heparin
• 6.7. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Inferior Vena Cava Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retrievable IVC Filters
• Permanent IVC Filters
• Advanced IVC Filter Systems
• 6.8. Global Deep Vein Thrombosis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombolytics
• Antiplatelet Agents
• Fibrinolytics
• Combination Therapy

7. Deep Vein Thrombosis Market Regional And Country Analysis

• 7.1. Global Deep Vein Thrombosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Deep Vein Thrombosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deep Vein Thrombosis Market

• 8.1. Asia-Pacific Deep Vein Thrombosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deep Vein Thrombosis Market

• 9.1. China Deep Vein Thrombosis Market Overview
• 9.2. China Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deep Vein Thrombosis Market

• 10.1. India Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deep Vein Thrombosis Market

• 11.1. Japan Deep Vein Thrombosis Market Overview
• 11.2. Japan Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deep Vein Thrombosis Market

• 12.1. Australia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deep Vein Thrombosis Market

• 13.1. Indonesia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deep Vein Thrombosis Market

• 14.1. South Korea Deep Vein Thrombosis Market Overview
• 14.2. South Korea Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deep Vein Thrombosis Market

• 15.1. Western Europe Deep Vein Thrombosis Market Overview
• 15.2. Western Europe Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deep Vein Thrombosis Market

• 16.1. UK Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deep Vein Thrombosis Market

• 17.1. Germany Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deep Vein Thrombosis Market

• 18.1. France Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deep Vein Thrombosis Market

• 19.1. Italy Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deep Vein Thrombosis Market

• 20.1. Spain Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deep Vein Thrombosis Market

• 21.1. Eastern Europe Deep Vein Thrombosis Market Overview
• 21.2. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deep Vein Thrombosis Market

• 22.1. Russia Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deep Vein Thrombosis Market

• 23.1. North America Deep Vein Thrombosis Market Overview
• 23.2. North America Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deep Vein Thrombosis Market

• 24.1. USA Deep Vein Thrombosis Market Overview
• 24.2. USA Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deep Vein Thrombosis Market

• 25.1. Canada Deep Vein Thrombosis Market Overview
• 25.2. Canada Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deep Vein Thrombosis Market

• 26.1. South America Deep Vein Thrombosis Market Overview
• 26.2. South America Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deep Vein Thrombosis Market

• 27.1. Brazil Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deep Vein Thrombosis Market

• 28.1. Middle East Deep Vein Thrombosis Market Overview
• 28.2. Middle East Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deep Vein Thrombosis Market

• 29.1. Africa Deep Vein Thrombosis Market Overview
• 29.2. Africa Deep Vein Thrombosis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Deep Vein Thrombosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Deep Vein Thrombosis Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deep Vein Thrombosis Market Competitive Landscape And Company Profiles

• 30.1. Deep Vein Thrombosis Market Competitive Landscape
• 30.2. Deep Vein Thrombosis Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi-Aventis U.S. LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Aspen Pharmacare Holdings Limited Overview, Products and Services, Strategy and Financial Analysis

31. Deep Vein Thrombosis Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Mylan N.V.
• 31.3. Bayer AG
• 31.4. Boehringer Ingelheim GmbH
• 31.5. Medtronic PLC
• 31.6. Hikma Pharmaceuticals PLC
• 31.7. Laboratorios Farmaceuticos Rovi S.A.
• 31.8. Cardinal Health Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. AstraZeneca PLC
• 31.11. Stryker Corporation
• 31.12. Cook Medical Incorporated
• 31.13. Boston Scientific Corporation
• 31.14. Arjo AB
• 31.15. DJO Global Inc.

32. Global Deep Vein Thrombosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deep Vein Thrombosis Market

34. Recent Developments In The Deep Vein Thrombosis Market

35. Deep Vein Thrombosis Market High Potential Countries, Segments and Strategies

• 35.1 Deep Vein Thrombosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Deep Vein Thrombosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Deep Vein Thrombosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer